Αποτελέσματα Αναζήτησης
25 Νοε 2019 · CapVest, which specializes in mid-market buyouts, has hired JPMorgan and Rothschild to find a new owner for the Paris-based firm which makes nuclear tracers used in diagnostic imaging ...
8 Απρ 2024 · (Paris, France – 8 th April 2024) – Curium, a world leader in nuclear medicine, announced today that it has entered into an agreement with Eczacıbaşı Holding and Bozlu Group for the acquisition of Eczacıbaşı-Monrol Nuclear Product Co. (Monrol), a dedicated specialist in nuclear medicine.
Limited partners in the 2013-vintage CapVest Equity Partners III were given the opportunity to sell their holdings in nuclear medicine company Curium Pharma or roll into a continuation vehicle, according to two sources familiar with the matter.
9 Ιαν 2020 · CVC Capital Partners, Bain Capital, Clayton Dubilier & Rice, Nordic Capital and PAI Partners have submitted first-round bids to acquire Curium Pharma from CapVest in a deal that would value the company at $3 billion or more, according to Bloomberg.
26 Απρ 2023 · Curium Pharma, a French maker of medical imaging supplies, and buyout firm HIG Capital are among suitors shortlisted in the bidding for Cardinal Health Inc.’s nuclear medicine business, people familiar with the matter said.
20 Οκτ 2020 · Intermediate Capital Group (ICG) is indirectly acquiring over 25% of the shares of Europe's largest radiopharmaceuticals provider Curium Pharma, HBI can reveal, after owner Capvest earlier pulled a majority sales process because of COVID-19.
1 Ιουν 2021 · This is the second acquisition of a positron-emission-tomography (PET) radiopharmaceutical business by Curium this year after the acquisition of M2i, a leading Irish PET player, earlier this year.
